The Conference Forum was delighted to present the 6th annual DPharm: Disruptive Innovations to Advance Clinical Trials conference. We are dedicated to presenting the annual event that the life science industry can rely on for the latest thinking in clinical trials for 21st century drug development.
Insights into DPharm
DPharm 2015 Sessions
|Making Clinical Trials a Care
Option for Patients:
Piloting an Infrastructure
|Will the Mobile Phone be
|What Happens When a Rare
Disease Protocol is Co-Designed
by 250+ Patients and 60+ MDS?
|Andreas Koester, MD, PhD
VP, Clinical Trial Innovation & External Alliances
|Craig Lipset, MBA
Head of Clinical Innovation, R&D
It was a daunting task to develop the first industry forum on thinking radically differently about the way we perform clinical trials, but the result was this conference. The event was launched in September 2011 with 125 disruptive thinkers and change makers eager to discuss current solutions in clinical development, propose innovative changes, and commit to testing and sharing the results in order to transform drug development and the industry.
The first DPharm addressed virtual clinical trial models, adaptive design thinking, the role of EHRs in clinical data, open source, telemedicine, and self-reported patient data among many other ideas. I remember Dr Tomasz Sablinski, Founder, Transparency Life Sciences saying it was the first event he had attended in a long time where he did not leave feeling depressed.
By the time the 2nd annual DPharm program took place, the concept of applying disruptive thinking to clinical development had taken root, with many attendees bearing titles with clinical innovation in them. Fast forward to 2016, the 6th annual program addresses a jam packed agenda on the latest in innovative thinking to advance clinical trials. Not all innovation is disruptive, of course, but as a community, we can continue to drive change that helps bring down millions of dollars in clinical trials while greatly enhancing the patient experience to ultimately bring more drugs to those who need them most.
Radical Thinkers are Especially Welcome
- DPharm is a TED-style event showcasing innovations from leading Pharma R&D practitioners and from other industries.
- DPharm underscores the promise and challenge of innovation in advancing drug development.
- DPharm features new models and collaborations to get therapeutics to patients faster.
- DPharm features the full spectrum of clinical research options and utilizes insights more appropriately.
- DPharm is dedicated to challenging creative solutions and finding a way to implement them.
- DPharm explores to whom are companies being disruptive and to gain a better understanding of the impact on clinical trials.
You are welcome to contact us at firstname.lastname@example.org to share your thoughts and ideas for the 2017 event.
"Congratulations on a very successful conference."
- Chandra Ramanathan, Bayer HealthCare, LLC
"Thank you! It was great...as usual!"
- Solomon Babani, BioPharma Solutions
"What an amazing meeting. So impressed!"
- John Brownstein, PhD, Boston Children’s Hospital
"Thank you for putting together such a great event. It was a pleasure working with each of you.It was a great experience."
- Amy Ripston, 4G Clinical
"Thanks and congrats again for a great DPharm2016, proud to have been part of this years edition."
- Bert Hartog, Janssen
"As usual, another outstanding DPharm!"
- Darshan Shah, AstraZeneca
"DPharm was excellent. Thanks for an excellent program."
- Ira Spector, PhD, ICON
"Unencumbered access to some incredibly brilliant minds, brought together by the obvious enjoyment they have in collaborating. I found the event quite inclusive. Thank you for making this a valuable learning experience."
- Marilyn Pratt, Medidata Solutions
"Dpharm was a must attend event for those looking at embedding Systemic Thinking and disruptive innovation into their work models."
- Michelle Shogren, Bayer
"I love coming back to DPharm as the 2014 edition changed my life. It was my first time at DPharm and prior to my attendance, I was working on innovation related to the way we design clinical trials. I recall being absolutely amazed by the spirit of collaboration. After the conference was over, I spent my Saturday connecting with speakers and attendees on Linkedin, thinking: I want to be part of this community! Two years later, my dream came true...I come back to find respected colleagues that became friends and collaborations, to exchange ideas and learn from each other!"
- Attendee, DPharm 2016